StockData
BioLineRx Ltd. logo

BioLineRx Ltd. (BLRX) stock

BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 3/30
$1.12−0.03 (-2.61%)

Close on Nov 17, 2026Market cap $4.87MP/E –Yield –

BioLineRx price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

BioLineRx's price to sales ratio was 5.2× on Nov 11, 2026, against 0.2× a year earlier. Over the last 3 years it ranged from 0.2× to 15.0×, with a median of 5.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.2×+5.0
2025Dec 31, 20250.2×−2.7
2024Dec 31, 20242.9×–

More BioLineRx figures

See a number that looks wrong?